Funders Back Centralized Bio Preprint Server

Major research funding agencies lend their support to an ASAPbio-led effort to streamline the banking of non–peer-reviewed manuscripts in the life sciences.

Written byBob Grant
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

PIXABAYThe US National Institutes of Health (NIH) and the U.K.’s Wellcome Trust are backing a consortium of biologists seeking to build a life science preprint server to rival the arXiv server that physicists have been using for decades. Today (February 13), ASAPbio issued a call to establish what it’s calling a “Central Service” to house life-science manuscripts that have not yet been peer reviewed. The NIH, the Wellcome Trust, the Alfred P. Sloan Foundation, the Howard Hughes Medical Institute (HHMI), and several other major biomedical research funders around the world have announced their support for the project.

“The landscape could become fragmented very quickly,” Robert Kiley, head of digital services at the Wellcome Trust told Nature. “We want to find a way of ensuring that, although this content is distributed far and wide, there’s a central place that brings it all together.”

Kiley was likely referring to the fact that life scientsts currently have many preprint server options to choose from: bioRxiv for biology, a quantitative biology section on arXiv, ChemRxiv for chemistry, and PsyArXiv for psychology, to name but a few. ASAPbio’s Central Service would try to bring all life-science preprints under one roof.

But not everyone is convinced that such an effort is necessary. As Rutgers University molecular biologist Richard Ebright tweeted: “There is no need to reinvent wheel. BioRxiv ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • From 2017 to 2022, Bob Grant was Editor in Chief of The Scientist, where he started in 2007 as a Staff Writer. Before joining the team, he worked as a reporter at Audubon and earned a master’s degree in science journalism from New York University. In his previous life, he pursued a career in science, getting a bachelor’s degree in wildlife biology from Montana State University and a master’s degree in marine biology from the College of Charleston in South Carolina. Bob edited Reading Frames and other sections of the magazine.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies